Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plant Extracts | 3 | 2024 | 286 | 0.540 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 78 | 0.530 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 110 | 0.500 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 2005 | 92 | 0.350 |
Why?
|
| Peyer's Patches | 1 | 2005 | 16 | 0.260 |
Why?
|
| Terpenes | 1 | 2005 | 28 | 0.250 |
Why?
|
| Thymus Gland | 1 | 2005 | 81 | 0.250 |
Why?
|
| Carcinogens | 1 | 2005 | 124 | 0.240 |
Why?
|
| Veronica | 1 | 2003 | 1 | 0.240 |
Why?
|
| Breast Neoplasms | 3 | 2003 | 1502 | 0.230 |
Why?
|
| Phytotherapy | 1 | 2003 | 81 | 0.220 |
Why?
|
| Cell Division | 1 | 2002 | 307 | 0.190 |
Why?
|
| Ethanol | 1 | 2002 | 192 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2003 | 807 | 0.160 |
Why?
|
| Vernonia | 1 | 2016 | 15 | 0.140 |
Why?
|
| Apoptosis | 2 | 2016 | 1398 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 259 | 0.130 |
Why?
|
| Neoplasms | 1 | 2024 | 1103 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 3 | 2003 | 502 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1198 | 0.090 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 2231 | 0.090 |
Why?
|
| Lead | 1 | 2010 | 93 | 0.080 |
Why?
|
| Cytochrome P-450 CYP3A | 2 | 2003 | 24 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2010 | 444 | 0.070 |
Why?
|
| Animals | 3 | 2016 | 15081 | 0.070 |
Why?
|
| Female | 3 | 2016 | 20969 | 0.070 |
Why?
|
| Methylcholanthrene | 1 | 2005 | 4 | 0.070 |
Why?
|
| Benz(a)Anthracenes | 1 | 2005 | 6 | 0.060 |
Why?
|
| Humans | 6 | 2024 | 37093 | 0.060 |
Why?
|
| Mice | 1 | 2016 | 5913 | 0.060 |
Why?
|
| Epithelium, Corneal | 1 | 2005 | 10 | 0.060 |
Why?
|
| Rats, Inbred Strains | 1 | 2005 | 133 | 0.060 |
Why?
|
| Microsomes | 1 | 2005 | 52 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2005 | 117 | 0.060 |
Why?
|
| HT29 Cells | 1 | 2024 | 45 | 0.060 |
Why?
|
| Epoxide Hydrolases | 1 | 2003 | 7 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2003 | 28 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2003 | 51 | 0.060 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2003 | 68 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2024 | 431 | 0.050 |
Why?
|
| Thymidine | 1 | 2002 | 15 | 0.050 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2003 | 88 | 0.050 |
Why?
|
| Liver | 1 | 2005 | 479 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2005 | 384 | 0.050 |
Why?
|
| Mitosis | 1 | 2002 | 99 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 169 | 0.050 |
Why?
|
| Antioxidants | 1 | 2024 | 416 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2002 | 859 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2024 | 938 | 0.040 |
Why?
|
| Rats | 1 | 2005 | 3483 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2002 | 1908 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 623 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2010 | 32 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2010 | 207 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 399 | 0.020 |
Why?
|
| Cataract | 1 | 2005 | 26 | 0.020 |
Why?
|
| Rabbits | 1 | 2005 | 283 | 0.020 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2003 | 30 | 0.010 |
Why?
|
| DNA Damage | 1 | 2005 | 352 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 562 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 1518 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1207 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 730 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 1015 | 0.010 |
Why?
|